In fact, constitutive activation of the JAK/STAT signaling pathway is considered the basic pathogenic mechanism of MPN, through either direct, as in patients harboring mutations of JAK2, or indirect, as for MPL or CALR mutations, involvement of JAK2, that in turn leads to sustained phosphorylation of STAT5. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.